AI-generated summary
The authors retrospectively reviewed 11 patients with melasma and subtle telangiectatic erythema treated with a 595-nm pulsed dye laser followed by a 1927-nm fractional diode laser. Six of eleven (54%) showed greater than 50% improvement, with no rebound melasma or adverse events reported. The authors note the findings suggest a link between vasculature and hyperpigmentation and call for further follow-up.
- Participants
- 11
- Who or what was studied
- Adults with melasma and subtle or sub-clinical telangiectatic erythema identified by spectrocolorimetry (10 women, 1 man; mean age 38.7 years; Fitzpatrick types II-IV)
- Wavelengths
- 595, 1927 nm
- Limits stated in the abstract
- Small retrospective case series with no control group, photographic grading by one physician, unmeasured photoprotection compliance, and an average follow-up of 96 days.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 8.5 J/cm2
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Fluence, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.